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There is now sucient evidence that non-invasive positive pressure ventilation (NIPPV) in selected patients with
severe hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease (COPD) is more eective
than pharmacological therapy alone. The aim of this study was to identify prognostic factors to predict the success
of this technique. Fifty-nine consecutive patients with COPD admitted to a respiratory ward for 75 episodes of
acute respiratory failure treated with NIPPV were analysed: success (77%) or failure (23%) were evaluated by
survival and the need for endotracheal intubation. There were no significant dierences in age, sex, cause of relapse
and lung function tests between the two groups. Patients in whom NIPPV was unsuccessful were significantly
underweight, had an higher Acute Physiology and Chronic Health Evaluation (APACHE) II score, and a lower
serum level of albumin in comparison with those in whom NIPPV was successful. They demonstrated significantly
greater abnormalities in pH and PaCO2 at baseline and after 2 h of NIPPV. The logistic regression analysis
demonstrated that, when all the variables were tested together, a high APACHE II score and a low albumin level
continued to have a significant predictive eect. This analysis could predict the outcome in 82% of patients. In
conclusion, our study suggests that low albumin serum levels and a high APACHE II score may be important
indices in predicting the success of NIPPV.
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Patients with chronic obstructive pulmonary disease
(COPD) are prone to exacerbations, especially with
progression of their disease, which can lead to hypercapnic
acute respiratory failure (1). The majority of cases of acute
respiratory failure can be treated in a conservative way, the
frequency of use of assisted ventilation varies from 16% to
35% in reported studies (2). Endotracheal intubation and
mechanical ventilation have been standard therapy when
conservative treatment fails. However, this technique
exposes the patient to several complications including local
airway injury and an increased risk of ventilator associated
pneumonia. Patients with COPD may be dicult to wean
from ventilation, often require tracheostomies due to the
length of intubation, and thus have prolonged stays in
intensive care units. Moreover, these patients cannot be
refused treatment because of the severity and chronic
nature of their disease. It is important to accurately
evaluate the recent and past history and to bear in mind
that severe COPD patients can live many years beyond theReceived 8 July 1999 and accepted in revised form 9 June 2000.
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0954-6111/00/100997+05 $35?00/0survival threshold indicated by forced expiratory volume in
1 sec FEV1 (3). The introduction of non-invasive ventila-
tory techniques have thus been particularly useful for
management of these patients.
Now there is evidence that the use of NIPPV in selected
patients with severe hypercapnic acute respiratory failure
due to COPD is more eective than pharmacological
therapy alone (4–7). The eectiveness of NIPPV results in a
significant reduction in rates of intubation and mortality
(8). There is concern, however, that when this approach is
unsuccessful, the delay in endotracheal intubation and
mechanical ventilation may adversely aect the outcome
(4, 9–11). The aim of this study was to identify prognostic
factors in order to predict whether patients with COPD
could be successfully treated with NIPPV and also to avoid
unnecessary delay in intubation of those who deteriorate on
NIPPV.
Materials and methods
PATIENTS
Between October 1996 and October 1998, 137 COPD
patients with acute respiratory failure were treated with
bilevel pressure support ventilation via a nasal or a facial# 2000 HARCOURT PUBLISHERS LTD
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females) admitted to a respiratory ward for 75 episodes of
acute respiratory failure were eligible for the study. All
patients, usually followed in our institution, were chroni-
cally hypoxaemic (PaO258?0 kPa breathing room air) and,
moderately hypercapnic (PaCO257?3 kPa) on long-term
oxygen therapy. All patients were judged to be in acute
respiratory failure and at risk of requiring endotracheal
intubation, based on the presence of respiratory distress
(severe diculty in breathing, increased respiratory rate,
intercostal or suprasternal retraction, increasing contribu-
tion of respiratory accessoty muscles, paradoxical respira-
tory movements), acute onset of severe hypercapnia
(PaCO248?7 kPa) and acute decrease in arterial blood pH
(57?35). Exclusion criteria were haemodynamic instability,
multiple organ system failure, respiratory arrest or need for
immediate intubation, inability to clear secretions and to
co-operate, and inability to tolerate the mask because of
discomfort. The patients were first treated in an emergency
room with conventional medical therapy (bronchodilators,
steroids, diuretics, controlled oxygen therapy delivered
either via 24–31% venturi mask or nasal prongs at 0?5–
2 lmin71). Afterwards, patients were transferred to a
respiratory ward where, if they met the criteria of the
protocol they were submitted to a short (2 h) trial of
NIPPV. Ventilation was delivered to the patient using a
BiPAP ST-D ventilator (Respironics; Murrysville, U.S.A.)
in spontaneous/timed (ST) mode, through a nasal or facial
mask. Masks were connected to the ventilator by a single
tube equipped with the Sanders NRV-2 valve (Respironics)
(BiPAP+SV) to prevent rebreathing of CO2. Bilevel
positive pressure ventilation was performed with a median
inspiratory positive airway pressure of 15 cm H2O (mini-
mum 10 cm H2O, maximum 20 cm H2O) and a median
expiratory positive airway pressure of 5 cm H2O (3–6 cm
H2O). Supplementary oxygen was added to the ventilator
circuit in order to achieve an arterial oxygen saturation
490%. If, after 2 h of BiPAP treatment, arterial gas value
improved, NIPPV was continued as long as tolerated, even
nocturnally, for a period ranging 6–24 h day71 according to
the patient’s clinical status and gas exchange data.
Patients in whom severe acute respiratory failure
persisted or worsened despite NIPPV were admitted to
the intensive care unit for intubation and conventional
mechanical ventilation. Criteria for endotracheal intuba-
tion and mechanical ventilation were at least one of the
following: (i) inability for the patient to clear tracheal
secretions; (ii) severe encephalopathy; (iii) increase in
respiratory rate up to 20% by comparison with baseline;
(iv) deterioration in gas exchange defined by greater than
20% fall in PaO2 or greater than 20% rise in cm PaCO2
compared with baseline; (iv) circulatory shock defined by a
sustained systolic blood pressure less than 80mm Hg.
DATA COLLECTION
The following data were collected from the clinical report:
age, sex, weight (kg), height (cm), body mass index
(kgm72) serum albumin levels (g l71), last spirometricparameters recorded during a period of clinical stability
within 1 year prior to admission. Causes of relapse
including the following definitions: (a) pneumonia—pre-
sence of lung infiltrates on the chest radiograph combined
with any three of the following: fever, positive blood
cultures, leucocytosis, or potential pathogenic bacterial
cultures from sputum; (b) exacerbation of COPD—
increased dyspnoea associated with no obvious cause for
respiratory compromise. APACHE II score (12) was
recorded at the moment of starting NIPPV. Arterial blood
gases were measured by arterial radial puncture immedi-
ately before (baseline) and 2 h after onset of NIPPV, with
all patients breathing oxygen. The arterial oxygen tension
(PaO2) was normalized by the fractional concentration of
inspired oxygen (PaO2/FiO2 ratio). Failure of NIPPV was
defined by the need for endotracheal intubation or death
during NIPPV.
STATISTICAL ANALYSIS
Comparison of dierences of successful versus unsuccessful
treatment was performed using Student’s unpaired t-test for
continuous variables. Dichotomous variables were com-
pared with w2-test with Yate’s correction. Comparison of
baseline data with those recorded during NIPPV was
performed using a paired t-test. A P-value of less than 0?05
was considered significant. The predictive models were
developed using discriminant logistic analysis. All the
variables shown on Table 1 were tested to reveal dierences
in variables behaviour between the successful and failure
group, after they have been tested by univariate procedure.
A software package (SYSTAT, Inc. Evanston, IL, U.S.A.)
was used for statistical analysis.
Results
NIPPV was successful in 58 episodes of acute respiratory
failure (77%) and unsuccessful in 17 patients (23%)
according to survival and to need for endotracheal
intubation. The overall mortality was 11?8% (seven of 59
patients). One patient died in our respiratory ward during
NIPPV, six patients in group 2 died despite endotracheal
intubation and invasive mechanical ventilation performed
in the intensive care unit. The most frequent cause of acute
respiratory failure in all patients was an exacerbation of
COPD (84%), pneumonia was found in 16%. Table 1
compares causes of acute respiratory failure, demographic,
anthropometric and clinical status in the group of patients
successfully treated with NIPPV and in the group in who
this failed. There were no significant dierences in age, sex,
causes of relapse and lung function tests between the two
groups. Patients in whom NIPPV was unsuccessful were
significantly underweight, had a higher APACHE II score,
and a lower level of serum albumin in comparison with
those in whom NIPPV was successful. Arterial blood gas
tension before and during the initial trial of NIPPV are
shown in Table 2. Patients in group 2 had significantly
lower baseline pH and higher PaCO2 than those in group 1.
The level of oxygenation as assessed by PaCO2/FiO2 was
TABLE 1. Demographic characteristics and physiological measurement of patients according to outcome of non-invasive
mechanical ventilation*
Group 1 Group 2 P-value
(n=47) (n=12)
Number of episodes of ARF 58 (77%) 17 (23%)
Age (years) 7010 707 NS
Weight (kg) 7522 6317 50?05
Body mass index (kgm72) 287 245 50?05
Albumin (gL71) 374 335 50?01
FEV1 % pred 3812 3714 NS
VC % pred 6211 6115 NS
FEV1 VC % 6310 6211 NS
Pneumonia n (%) 9 (15?5%) 3 (17?6%)
Exacerbation n (%) 49 (84?4%) 14 (82?3%)
APACHE II 173 214 50?001
Death n 1 6
*Data expressed as meanSD or absolute number and percentage.
TABLE 2. Blood gas levels (meansSD) at baseline and during non-invasive mechanical ventilation (NIPPV)
Group 1 Group 1
successful unsuccessful
Baseline NIPPV Baseline NIPPV
pH 7?290?05* 7?330?058 7?240?06* 7?260?06
PaCO2 mmHg8 9?791?54** 8?991?49
§ 11?611?77** 10?861?82
PaO2/FiO2 27?628?15 29?998?15 25?659?53 27?438?11
*P50?005 for dierence between baseline in groups 1 and 2.
**P50?0001 for dierence between baseline in groups 1 and 2.
8P50?001 for dierence between baseline and NIPPV in groups 1.
§P50?01 for dierence between baseline and NIPPV in group 1.
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in both groups (mean reduction in PaCO2 of 8?1% and
6?5% in group 1 and 2, respectively), but only significantly
so in group 1. In group 2 pH and PaCO2 remained severely
compromised. The logistic regression analysis demon-
strated that, when these variables were tested together, a
high APACHE II score (odds ratio: 1?33; 95% confidence
interval: 1?74–1?02) and a low serum albumin level (odds
ratio: 0?14; 95% confidence interval: 0?88–0?02) maintained
a significant predictive eect. The pH values after 2 h of
NIPPV were close to statistical significance. A predictive
modelling formula was constructed using these covariates.
The sensitivity of this model was 60?4% and the specificity
was 88?4%.
Discussion
In this retrospective study the success rate of 77% and
mortality rate of 11?8% are in agreement with previousstudies (9–11,13,14). The most common conditions leading
to acute respiratory failure in COPD are generally
associated with bronchial, and sometimes parenchymal,
infection (15). Pneumonia as a cause of acute respiratory
failure was found in a total of 19 patients out of 75 (16%)
with no significant dierences between the two groups. A
high failure rate among patients presenting underlying
pneumonia as the cause of respiratory failure has been
reported (13,16). In contrast, our study has reported much
lower failure rates for patients with pneumonia, which is in
accordance with previous findings (17,18). The diering
results of these studies may be attributed to the diversity of
patients treated: for example the patients in the Wysocki
study (16) were not aected by COPD. In another study by
Vitacca et al. (14) no significant dierence was found in
either admissions or in the 3-month mortality of all patients
with or without pneumonia, but the overall 1-year
mortality was greater in patients showing lung infiltrates.
In our study, the patients were also comparable in the
severity of their underlying respiratory disease, as assessed
1000 S. PUTINATI ET AL.by similar values of FEV1 measured in a stable state before
acute respiratory failure. Brochard et al. (5) reported
spirometric tests performed in survivors at 3 months with
no dierence between the two study groups. Most of the
literature has shown that the degree of airflow limitation
is a very reliable index of the severity and the outcome of
pulmonary disease (19–22). There is less evidence regarding
the clinical course of the subset of patients with severe
COPD. Long-term survival for these patients, variously
defined as those with an FEV1 less than 1 l or 35%
predicted, has been positively correlated to the presence of
a bronchodilator response and smoking cessation (23).
Rieves et al. (24) analysed COPD patients with acute
respiratory failure and reported that the severity of the
baseline obstruction alone was not predictive of short-term
survival while the mortality risk associated with the
presence of pulmonary infiltrates on chest X-ray increased
dramatically with declining baseline lung function. These
conclusions reflect the inclusion of patients with a broad
range of pulmonary functional impairment. Unsuccessful
NIPPV was associated with reduced body weight, expressed
as absolute and as body mass index, and a lower level of
serum albumin. Our data confirm that malnutrition appears
to be a risk factor for prognosis confirming the findings of
previous reports (13,24–26). Poor nutritional status can
adversely aect pulmonary function, not only by impair-
ment of respiratory muscle strength and excercise tolerance
(27,28), but also by decreased ventilatory drive and altered
lung defence mechanism (29). Some authors (30,31,32)
reported worse outcomes in COPD patients with low serum
albumin levels. It is possible that visceral proteins reflect
the severity of disease and prognosis in critically ill
hospitalized patients, more than nutritional status or
adequacy of nutritional support (33,34). In our study, the
most important independent predictor of outcome was the
overall severity of illness on admission as measured by the
APACHE II score. The APACHE II scoring system has
been shown to have a significant correlation with outcome
and mortality in patients with acute respiratory failure due
to a variety of pathologies (12), including severe COPD
(32). In a study by Vitacca et al. (21), the APACHE II score
is seen to be able to prognostically stratify patients and is
correlated with a nutritional profile. In a study by
Confalonieri et al. (35) a high APACHE II score seems to
be correlated with a failure to ventilate with NIPPV.
Particularly, an APACHE II score of more than 29 seems
to be predictive of failure. In our study we find a significant
dierence in admission level of acidosis and hypercapnia
between patients successfully ventilated with NIPPV and
those who failed with NIPPV. NIPPV was eective in
reducing PaCO2 levels and pH in both groups of patients.
Nevertheless, the absolute level of PaCO2 and pH after
the initial trial of NIPPV are significantly lowered only in
the patients which are successfully ventilated, while in
group 2 patients the values remained severely compro-
mised. Acidosis is an important prognostic factor for acute
respiratory failure. A number of studies has confirmed that
rapid improvement in the blood pH is crucial for successful
ventilation (4,5,10,13,36). Ambrosino et al. (13) found
that in a multivariate context only baseline pH had asignificant independent predictive eect of success with
ventilation, which was greater when acidosis was less
severe. Baseline pH showed a sensitivity of 97% and a
specificity of 71%, but this analysis was related only to 41
patients. The use of arterial blood gas tension measured at
dierent levels of FiO2 has been questioned. However,
seeing that our patients were both hypoxaemic and
hypercapnic and on long-term oxygen therapy, we were
obliged to administer O2 at the lowest levels of FiO2
maintain SaO2 over 90%. The level of PaO2/FiO2 did not
dier between successful and unsuccessful cases, so we are
confident, in accordance with Ambrosino et al. (13), that
the level of oxygenation did not influence the values in
PaCO2 of the two groups. The logistic regression analysis
demonstrated that, when all the variables present in Table 1
were tested together, only a high APACHE II score and a
low albumin level maintained a significant predictive eect.
This analysis could correctly predict the outcome of NIPPV
in 82% of the patients. In particular, the logistic regression
analysis showed a sensitivity of 60% and a specificity of
88%. In conclusion, unsuccessful employment of NIPPV
may depend not only on the severity of the underlying lung
disease (FEV1) or on the arterial blood gas values (PaCO2,
pH) obtained before initiating ventilation, but also on
systemic factors such poor nutrition (body mass index,
albumin) or on comorbidity and severity of the acute
exacerbation (APACHE II score). Further research will be
required to identify factors that predict success of NIPPV
more accurately, and it is essential that conventional
mechanical ventilation by endotracheal intubation be
available promptly.
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